VoxCell empowers scientists and drug developers to study drug behaviour with unprecedented physiological relevance. With vascular complexity at the core of our innovation, VoxCell delivers human-like models that accelerate therapeutic discovery and bridge the gap between preclinical and clinical phases. Committed to innovation and excellence, VoxCell continues to expand its impact on a global scale. Complex tissue models for preclinical screening. Efficacy to vascular toxicity. Matching your requirements ensuring optimal performance for drug screening. VoxCell’s tissues allow long term and multi-dose studies (80%+ for up to 21 days*). Features include: Physiologically relevant, Multicellular structures, Highly reproducible, 3D capillary vessels, Customizable dimensions and vasculature, Unidirectional flow.